Intellia Therapeutics Faces a Setback as Q2 2024 Earnings and Revenues Miss Estimates
Aug 10, 2024
REGN Equities
Regeneron Teams Up with Mammoth Biosciences for Innovative CRISPR Gene Editing Advancements
Apr 25, 2024
S&P 500 Index Peaks: Spotlight on 5 High-Growth Stocks for 2024
Jan 22, 2024
Comparative Performance of DRTS and REGN in the Medical Sector
Jan 22, 2024
Five Prominent Large-Cap Stocks to Watch in January
Jan 4, 2024